Metabolism: clinical and experimental · 2026
Hepatic estrogen receptor α contributes to stage-specific coupling of liver metabolism and proliferation during pregnancy.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Meda Clara, Dolce Arianna, Talamazzini Giacomo, Ohlsson Claes, Carli Fabrizia, Infelise Patrizia, Gastaldelli Amalia, Maggi Adriana, Torre Sara Della
Аннотация
BACKGROUND AND AIMS: Pregnancy requires dynamic, stage-specific adaptations of maternal liver metabolism and growth to sustain fetal development while preserving systemic homeostasis. Estrogen signaling increases markedly during pregnancy and is primarily mediated in hepatocytes by estrogen receptor α (ERα). Although hepatic ERα regulates female liver metabolism under non-pregnant conditions, its contribution to pregnancy-induced hepatic remodeling remains unclear.
METHODS: We studied non-pregnant and pregnant control and liver-specific ERα knockout (LERKO) mice across gestational stages using longitudinal physiological measurements, liver transcriptomics, targeted metabolomics, histological assessment of cell proliferation, and metabolic phenotyping.
RESULTS: In control mice, pregnancy elicited sequential hepatic remodeling, with early induction of cell-cycle programs, a mid-gestational peak of hepatocyte proliferation accompanied by transient suppression of metabolic pathways, and late metabolic reactivation. Chronic hepatic ERα deficiency altered this temporal pattern. LERKO livers showed premature activation of proliferative and anabolic transcriptional programs, an early increase in mTORC1-related S6 phosphorylation relative to the non-pregnant state, and changes in amino acid- and fatty acid-related metabolic pathways. At mid-gestation, LERKO mice displayed reduced hepatocyte proliferation, altered expression of metabolic and insulin-related genes, blunted gestational improvement in glucose tolerance with no detectable genotype difference in insulin tolerance, and altered light/dark-phase metabolic organization.
CONCLUSIONS: These findings indicate that hepatic ERα contributes to the appropriate stage-specific coupling of liver growth, metabolic remodeling, and insulin-responsive signaling during pregnancy. Its loss is associated with gestational hepatic maladaptation and altered systemic metabolic responses, providing a framework for investigating estrogen-dependent mechanisms in pregnancy-associated metabolic and liver disorders.
METHODS: We studied non-pregnant and pregnant control and liver-specific ERα knockout (LERKO) mice across gestational stages using longitudinal physiological measurements, liver transcriptomics, targeted metabolomics, histological assessment of cell proliferation, and metabolic phenotyping.
RESULTS: In control mice, pregnancy elicited sequential hepatic remodeling, with early induction of cell-cycle programs, a mid-gestational peak of hepatocyte proliferation accompanied by transient suppression of metabolic pathways, and late metabolic reactivation. Chronic hepatic ERα deficiency altered this temporal pattern. LERKO livers showed premature activation of proliferative and anabolic transcriptional programs, an early increase in mTORC1-related S6 phosphorylation relative to the non-pregnant state, and changes in amino acid- and fatty acid-related metabolic pathways. At mid-gestation, LERKO mice displayed reduced hepatocyte proliferation, altered expression of metabolic and insulin-related genes, blunted gestational improvement in glucose tolerance with no detectable genotype difference in insulin tolerance, and altered light/dark-phase metabolic organization.
CONCLUSIONS: These findings indicate that hepatic ERα contributes to the appropriate stage-specific coupling of liver growth, metabolic remodeling, and insulin-responsive signaling during pregnancy. Its loss is associated with gestational hepatic maladaptation and altered systemic metabolic responses, providing a framework for investigating estrogen-dependent mechanisms in pregnancy-associated metabolic and liver disorders.